MedicineEndocrinologyPharmacologyEndocrine PharmacotherapyMetabolic RegulationReproductive EndocrinologyDiabetes ManagementDiabetes MellitusGynecologic EndocrinologyInsulin ResistanceOvarian PhysiologyPolycystic Ovary SyndromeMenstrual Cycle EndocrinologyMenstrual Cycle PhasesMenstrual Cycle RegulationOvulation PhysiologyPolycystic Ovary Syndrome ManagementPolycystic Ovary Syndrome PharmacotherapyPolycystic Ovary Syndrome TreatmentPolycystic Ovary Syndrome-associated Insulin Resistance
Oligo-anovulation, hyperandrogenism and insulin resistance characterizes polycystic ovary syndrome (PCOs). Metformin is the oldest insulin sensitizer used in the management of type 2 diabetes mellitus. In PCOs, metformin decreases the serum lipids, androgen and insulin; induces ovulation and regular menstrual cycle; increases the pregnancy rate.
28
Role of AMP-activated protein kinase in mechanism of metformin action
Gaochao Zhou, Robert P. Myers, Ying Li et al. · Journal of Clinical Investigation · 2001 · 5.4K citations
Kenneth R. Watterson, Dawn Bestow, Jennifer Gallagher et al. · Neurosignals · 2012 · 3.4K citations · Full text